Deutsche Bank Says Dendreon (DNDN) CEO Departure a "Surprise," But New CEO Brings M&A History
Get Alerts DNDN Hot Sheet
Price: $0.13 --0%
Rating Summary:
2 Buy, 15 Hold, 9 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Rating Summary:
2 Buy, 15 Hold, 9 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Join SI Premium – FREE
Deutsche Bank offers some quick comments on Dendreon (NASDAQ: DNDN) following news CEO Gold is stepping down, being replaced by John Johnson.
The firm note that Gold is stepping down by "choice" with the company stating this was part of a succession plan that Gold started a while ago. Nonetheless it takes investors by surprise, they said.
On the new CEO Johnson, the firm highlights that he has a history of M&A. He successfully sold ImClone to Eli Lilly & attempted to sell Savient.
"M&A history of new CEO & a fresh perspective might benefit the company's near term strategy. We will have more opinion once we understand Johnson's strategy for the company."
The firm maintained their Buy rating and $20 price target on DNDN.
For an analyst ratings summary and ratings history on Dendreon click here. For more ratings news on Dendreon click here.
Shares of Dendreon closed at $13.58 yesterday.
The firm note that Gold is stepping down by "choice" with the company stating this was part of a succession plan that Gold started a while ago. Nonetheless it takes investors by surprise, they said.
On the new CEO Johnson, the firm highlights that he has a history of M&A. He successfully sold ImClone to Eli Lilly & attempted to sell Savient.
"M&A history of new CEO & a fresh perspective might benefit the company's near term strategy. We will have more opinion once we understand Johnson's strategy for the company."
The firm maintained their Buy rating and $20 price target on DNDN.
For an analyst ratings summary and ratings history on Dendreon click here. For more ratings news on Dendreon click here.
Shares of Dendreon closed at $13.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades Oxford Biomedica (OXB:LN) (OXBDF) to Hold
- Barclays Starts Centrus Energy Corp. (LEU) at Equalweight
- Jefferies Starts Tamarack Valley Energy Ltd. (TVE:CN) at Buy
Create E-mail Alert Related Categories
Analyst Comments, RumorsRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share